These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents. Jochmanova I; Abcede AMT; Guerrero RJS; Malong CLP; Wesley R; Huynh T; Gonzales MK; Wolf KI; Jha A; Knue M; Prodanov T; Nilubol N; Mercado-Asis LB; Stratakis CA; Pacak K J Cancer Res Clin Oncol; 2020 Apr; 146(4):1051-1063. PubMed ID: 32062700 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma. Hensen EF; Bayley JP Fam Cancer; 2011 Jun; 10(2):355-63. PubMed ID: 21082267 [TBL] [Abstract][Full Text] [Related]
12. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations. Baysal BE; Maher ER Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606 [TBL] [Abstract][Full Text] [Related]
13. Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations. Bayley JP; Oldenburg RA; Nuk J; Hoekstra AS; van der Meer CA; Korpershoek E; McGillivray B; Corssmit EP; Dinjens WN; de Krijger RR; Devilee P; Jansen JC; Hes FJ BMC Med Genet; 2014 Oct; 15():111. PubMed ID: 25300370 [TBL] [Abstract][Full Text] [Related]
14. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase. Gupta S; Zhang J; Erickson LA Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484 [TBL] [Abstract][Full Text] [Related]
15. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers. Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114 [TBL] [Abstract][Full Text] [Related]
16. A Guide to Pheochromocytomas and Paragangliomas. Guilmette J; Sadow PM Surg Pathol Clin; 2019 Dec; 12(4):951-965. PubMed ID: 31672301 [TBL] [Abstract][Full Text] [Related]
17. Models of parent-of-origin tumorigenesis in hereditary paraganglioma. Hoekstra AS; Devilee P; Bayley JP Semin Cell Dev Biol; 2015 Jul; 43():117-124. PubMed ID: 26067997 [TBL] [Abstract][Full Text] [Related]
18. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma. Nakamura E; Kaelin WG Endocr Pathol; 2006; 17(2):97-106. PubMed ID: 17159241 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas. Cassol CA; Winer D; Liu W; Guo M; Ezzat S; Asa SL Mod Pathol; 2014 Aug; 27(8):1050-62. PubMed ID: 24390213 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]